• mimetic
  • The second kind of incretin-increasing medicine is called an incretin mimetic. (diabeteshealth.com)
  • The statement indicated that the FDA has not reached any new conclusions about safety risks with incretin mimetic drugs, and recommended that patients continue to take their medicine as directed until they talk to their health care professional, and that health care professionals continue to follow the prescribing recommendations in the drug labels. (thestreet.com)